Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer.

Liu, Yibin; Liu, Shouze; Yan, Lu; Zhang, Qianqian; Liu, Wenhua; Huang, Xianghua; Liu, Shikai

Liu, Yibin; Liu, Shouze; Yan, Lu; Zhang, Qianqian; Liu, Wenhua; Huang, Xianghua; Liu, Shikai.

Afiliación

Liu Y; Department of Gynecology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, Hebei 050011, China.
Liu S; Department of Gynecology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, Hebei 050011, China.
Yan L; Department of Gynecology III, Cangzhou Central Hospital, Cangzhou, Hebei 061000, China.
Zhang Q; Department of Gynecology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, Hebei 050011, China.
Liu W; Department of Gynecology and Obstetrics, Beijing Tsinghua Changgung Hospital, Beijing 102218, China.
Huang X; Department of Pain, Cangzhou Hospital of Integrated TCM-WM Hebei, Cangzhou, Hebei 061001, China.
Liu S; Department of Gynecology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, Hebei 050011, China.

Mediators Inflamm ; 2023: 1400267, 2023.

Article en En | MEDLINE | ID: mdl-38022687

Asunto(s)

Neoplasias Ováricas; Humanos; Femenino; Neoplasias Ováricas/genética; Neoplasias Ováricas/terapia; Pronóstico; Bases de Datos Factuales; Inmunoterapia; ARN; Microambiente Tumoral/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Límite: Female / Humans Idioma: En Revista: Mediators Inflamm Asunto de la revista: BIOQUIMICA / PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google